Full Text

Turn on search term navigation

© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objective

To assess progression of semantic loss in early stages of cognitive decline using semantic and letter fluency performance, and its relation with Alzheimer's disease (AD)‐specific neurodegeneration using longitudinal multimodal neuroimaging measures.

Methods

Change in verbal fluency was analyzed among 2261 non‐demented individuals with a follow‐up diagnosis of no mild cognitive impairment (MCI), amnestic MCI (aMCI), non‐amnestic MCI (naMCI), or incident dementia, using linear mixed models across 4 years of follow‐up, and relations with magnetic resonance imaging (MRI; n = 1536) and 18F‐fluorodeoxyglucose brain positron emission tomography (18F‐FDG‐PET) imaging (n = 756) using linear regression models across 2 years of follow‐up.

Results

Semantic fluency declined—fastest in those at higher risk for AD (apolipoprotein E [APOE] e4 carriers, Clinical Dementia Rating score of .5, aMCI, or incident dementia)—while letter fluency did not except for those with incident dementia. Lower baseline semantic fluency was associated with an increase in white matter hyperintensities and total mean cortical thinning over time, and regionally with less hippocampal volume as well as more cortical thinning and reduced 18F‐FDG‐PET uptake in the inferior parietal lobule, entorhinal cortex, isthmus cingulate, and precuneus–posterior cingulate area. In contrast, baseline letter fluency was not associated with change in total nor regional neurodegeneration. Whole‐brain neurodegeneration over time was associated with faster decline in both fluencies, while AD‐specific regions were associated with a faster rate of decline in semantic but not letter fluency.

Interpretation

This study provides strong evidence of distinctive degeneration of semantic abilities early on in relation to both cognitive decline and AD‐specific neurodegeneration.

Details

Title
Semantic loss marks early Alzheimer's disease‐related neurodegeneration in older adults without dementia
Author
Vonk, Jet M J 1 ; Bouteloup, Vincent 2 ; Jean‐François Mangin 3 ; Dubois, Bruno 4 ; Blanc, Frédéric 5 ; Gabelle, Audrey 6 ; Ceccaldi, Mathieu 7 ; Annweiler, Cédric 8 ; Pierre Krolak‐Salmon 9 ; Belin, Catherine 10 ; Thérèse Rivasseau‐Jonveaux 11 ; Julian, Adrien 12 ; Sellal, François 13 ; Magnin, Eloi 14 ; Chupin, Marie 15 ; Marie‐Odile Habert 16 ; Chêne, Geneviève 2 ; Dufouil, Carole 2 

 Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA; Julius Center for Health Sciences and Primary Care, Department of Epidemiology, University Medical Center Utrecht, Utrecht, the Netherlands 
 Centre Inserm U1219, d'Epidémiologie et de Développement (ISPED), Bordeaux School of Public Health, Institut de Santé Publique, Université de Bordeaux, Bordeaux, France; Pole de sante publique, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France 
 CATI Multicenter Neuroimaging Platform, Paris, France; Neurospin, CEA, Paris Saclay University, Gif‐sur‐Yvette, France 
 IM2A, AP‐HP, INSERM, UMR‐S975, Groupe Hospitalier Pitié‐Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer, Institut du Cerveau et de la Moelle épinière, Sorbonne Université, Paris, France 
 Hôpitaux Universitaire de Strasbourg, CM2R (Centre Mémoire de Ressource et de Recherche), Hôpital de jour, pôle de Gériatrie, et CNRS, laboratoire ICube UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), team IMIS, Strasbourg, France 
 Centre Mémoire Ressources Recherche, Département de Neurologie, CHU Gui de Chauliac, Montpellier, France; Inserm U1061, La Colombière, Université de Montpellier, Montpellier, France 
 CMMR PACA Ouest, CHU Timone, APHM & Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France 
 Department of Geriatric Medicine, Angers University Hospital, Angers, France; Angers University Memory Clinic, Angers, France; Research Center on Autonomy and Longevity, Angers, France; UPRES EA 4638, University of Angers, Angers, France; Robarts Research Institute, Department of Medical Biophysics, Schulich School of Medicine and Dentistry, the University of Western Ontario, Ontario, London, Canada 
 Institut du Vieillissement, Centre Mémoire Ressources Recherche de Lyon, Hospices civils de Lyon, Université Lyon 1, Inserm U1048, Lyon, France 
10  Service de Neurologie, Hôpital Saint‐Louis AP‐HP, Paris, France 
11  Centre Mémoire de Ressources et de Recherche de Lorraine Unité Cognitivo Comportementale CHRU Nancy, Laboratoire Lorrain de Psychologie et de Neurosciences de la dynamique des comportements 2LPN EA 7489 Université de Lorraine, Nancy, France 
12  Service de Neurologie, CHU La Milétrie, Centre Mémoire de Ressources et de Recherche, Poitiers, France 
13  CMRR Département de Neurologie, Hôpitaux Civils, Colmar, France; INSERM U‐1118, Université de Strasbourg. Faculté de Médecine, Strasbourg, France 
14  Centre Mémoire Ressources et Recherche (CMRR), service de Neurologie, CHRU Besançon, Besançon, France; Neurosciences intégratives et cliniques EA481, Univ. Bourgogne Franche‐Comté, Besançon, France 
15  CATI Multicenter Neuroimaging Platform, Paris, France 
16  CATI Multicenter Neuroimaging Platform, Paris, France; CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, Sorbonne Université, Paris, France; AP‐HP, Hôpital Pitié‐Salpêtrière, Médecine Nucléaire, Paris, France 
Section
COGNITIVE & BEHAVIORAL ASSESSMENT
Publication year
2020
Publication date
2020
Publisher
John Wiley & Sons, Inc.
e-ISSN
23528729
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2635816407
Copyright
© 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.